Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir™: a Potential Treatment for Covid-19
16 déc. 2021 12h25 HE
|
Todos Medical Ltd.
Webinar to be held on December 22nd @ 12pm EST NLC Pharma and Todos agree to extend closing date for formation of 3CL Sciences to December 31, 2021 while the companies complete legal due diligence ...
Todos Medical Enters 90-Day Extension of Agreement with Convertible Note Holders on Moratorium on Conversions of Convertible Notes
13 déc. 2021 07h30 HE
|
Todos Medical Ltd.
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Dec. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...
Todos Medical Interview and Presentation on Benzinga's All Access Conference Live December 14th at 10:20 AM EST
10 déc. 2021 12h29 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces 2 New COVID-19 PCR Testing Reference Lab Agreements for CLIA/CAP Lab Provista Diagnostics
07 déc. 2021 09h19 HE
|
Todos Medical Ltd.
Combined testing from two contracts averages 1,000 PCR samples per dayTesting potential for the two contracts could ramp up to 5,000 PCR samples per day New York, NY, Alpharetta, GA and Tel...
Todos Medical to Present at Upcoming Emerging Growth Conference
06 déc. 2021 15h14 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation
02 déc. 2021 06h00 HE
|
Todos Medical Ltd.
Dr. Jules Mitchel now leading preparation for data lock and statistical analysisBusiness update call Today at 4:30PM EST New York, NY, and Tel Aviv, ISRAEL, Dec. 02, 2021 (GLOBE NEWSWIRE) -- via...
Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST
01 déc. 2021 16h05 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
30 nov. 2021 10h35 HE
|
Todos Medical Ltd.
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IPDr. Dorit...
Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant
30 nov. 2021 08h39 HE
|
Todos Medical Ltd.
Provista to also utilize Osang’s High-Capacity Reflex Variant PCR Detection Kit that has been confirmed to identify the Omicron variant New York, NY, and Tel Aviv, ISRAEL, Nov. 30, 2021 (GLOBE...
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
29 nov. 2021 09h08 HE
|
Todos Medical Ltd.
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP Dr....